Brighter acquires Camanio AB and decides on a non-cash issue.
Brighter AB (publ) ("Brighter") has on this day acquired all shares in Camanio AB in accordance with the previously announced share transfer agreement between Brighter and Camanio Care AB (publ) ("Camanio Care") on September 29, 2019. A prerequisite for the acquisition was that Camanio Care's operations had been transferred to Camanio AB, which took place and was announced today.
The purchase price for Camanio AB amounts to SEK 17 million and was paid through a non-cash issue in which Brighter issued and allotted 1,597,744 shares to the seller Camanio Care, and Camanio Care transferred the shares in Camanio AB as capital contributed in kind. The subscription price per share was SEK 10.64, which corresponds to the volume-weighted average price during the 20 trading days preceding this day. The rights issue increases Brighter's share capital by SEK 79,887.20. The decision on the rights issue was made by the Board of Directors with authorization from the Annual General Meeting on May 9, 2019.
“The Camanio operations will be completely independent in the form of a separate subsidiary with its own management and board, while Brighter will continue to focus on selling the Actiste service and developing new application areas,” says Henrik Norström, Brighter's CEO.
Camanio is a welfare technology company that develops innovative solutions for high quality home care. The company offers digital service platforms within care, robotics, tools and gamification to support people's basic needs and increase accessibility and quality in healthcare.
For further information, please contact:
Henrik Norström, CEO
Phone: +46 733 40 30 45
Email: henrik.norstrom@brighter.se
Ann Zetterberg, CFO
Phone: +46 708 37 21 23
E-mail: ann.zetterberg@brighter.se
About Brighter AB (publ).
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to provide smarter care for chronic conditions. Our daily-care solutions facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – improving quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. https://brighter.se/
The Company's shares are listed on Nasdaq First North Growth Market/BRIG. Brighter’s Certified Adviser is Eminova Fondkommission AB, +46 (0)8 – 684 211 00, info@eminova.se, www.eminova.se.